en
E-mail us
(925) 558-5040
bd_global@crystalpharmatech.com
 cn
cn

BIO International Convention

We're Heading to BIO2025 in Boston!  

Crystal Pharmatech is excited to announce our participation in the BIO International Convention from June 16-19 in Boston! 
 
Our senior leadership team from CRO and CDMO business units will be on-site, ready to discuss how our small molecule and biologics expertise can help accelerate your First-in-Human and clinical development programs. 


 

Event Details

When: June 16-19, 2025 

Where: Boston Convention & Exhibition Center 

Find Us: Booth #1285

Join Us
at the Biotech Reception

Ready for an evening of unscripted connection?


Please complete the form to register for our San Diego Biotech and Pharma R&D social. Note: Registration is subject to review. You will receive a formal confirmation email once your attendance is approved.



By providing your e-mail address, you agree to receive an e-mail response from Crystal Pharmatech to your registration. The information you submit will be governed by our Privacy Policy.


Schedule a Meeting
Related Resources
A Significant Step Toward Greater Clarity in Polymorph Control for Innovative Drugs
News
A Significant Step Toward Greater Clarity in Polymorph Control for Innovative Drugs
28 Jan 2026
Brise Pharma Presents“Best Partner”Trophy to Crystal Formulation Services, Recognizing Their Excellence in Drug Product CDMO Services
News
Brise Pharma Presents“Best Partner”Trophy to Crystal Formulation Services, Recognizing Their Excellence in Drug Product CDMO Services
04 Dec 2025
Crystal Pharmatech Receives CNAS Reaccreditation, Scope Expansion, and Address Approval
News
Crystal Pharmatech Receives CNAS Reaccreditation, Scope Expansion, and Address Approval
11 Aug 2025
Small Molecule
Mol2Med™ Integrated Services Developability Assessment API Form and Solid-State Research Crystallization Development Services Pre-formulation Studies Formulation and Analytical Development GMP Manufacturing Clinical Supply
Crystal Bio Solutions
Biologics Characterization and CMC Analytics Bioanalytical and Biomarker Services Quantitative Clinical Pharmacology (QCP)
Crystal NAX
DNA Synthesis RNA Synthesis LNP Formulation Services Analytical & Characterization Services Early-Phase Manufacturing Catalogue Products
Technology
Solid Form Screening Solid Form Developability Evaluation Absolute Structure Determination Crystallization Process Development Conventional Oral Solid Dosage Forms Bioavailability Enhancement for Insoluble Compounds & PROTAC & Oral Peptides Mini-tablet
Quick Links
Highlights News Events Knowledge Hub Webinar Series
Contact Us
bd_global@crystalpharmatech.com (925) 558-5040
U.S
NJ Sites: Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey, USA 08512

2005 Eastpark Blvd, Cranbury, New Jersey, USA 08512

CA Site: 7133 Koll Center Parkway, Suite 200, Pleasanton, California, USA 94566
Canada
6800 Kitimat Rd, Unit 1, Mississauga, Ontario, Canada L5N 5M1
China
No. 288, Jiangyun Road, Suzhou Industrial Park, Suzhou, China 215123

Subscribe to be the first to get the updates!

Subscribe to be the first to get the updates!
Privacy Policy
Sitemap
Small Molecule
Mol2Med™ Integrated Services Developability Assessment API Form and Solid-State Research Crystallization Development Services Pre-formulation Studies Formulation and Analytical Development GMP Manufacturing Clinical Supply
Crystal Bio Solutions
Biologics Characterization and CMC Analytics Bioanalytical and Biomarker Services Quantitative Clinical Pharmacology (QCP)
Technology
Quick Links
About Us Events
NJ Sites: Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey, USA 08512

2005 Eastpark Blvd, Cranbury, New Jersey, USA 08512

CA Site: 7133 Koll Center Parkway, Suite 200, Pleasanton, California, USA 94566
bd_global@crystalpharmatech.com (925) 558-5040
Privacy Policy
Sitemap